Marc A Cohen C4 Therapeutics, Inc. (CCCC) insider trading activity

Marc A Cohen is Director of C4 Therapeutics, Inc.. Currently has a direct ownership of 1,118 shares of CCCC, which is worth approximately $7,188. The most recent transaction as insider was on Jan 04, 2022, when has been sold 657 shares (Common Stock) at a price of $31.58 per share, resulting in proceeds of $20,748. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 1.12K

0% 3M change

0% 12M change

Total Value Held $7,188

MARC A COHEN Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Jan 04 2022	BUY Grant, award, or other acquisition	$20,748 $31.58 p/Share	657 Added 37.01%	1,118 Common Stock
Oct 04 2021	BUY Grant, award, or other acquisition	$20,740 $44.99 p/Share	461 Added 50.0%	461 Common Stock
Jul 02 2021	BUY Grant, award, or other acquisition	$20,734 $39.72 p/Share	522 Added 7.29%	6,641 Common Stock
Jun 14 2021	BUY Other acquisition or disposition	-	92,817 Added 48.4%	98,936 Common Stock
Apr 05 2021	BUY Grant, award, or other acquisition	$20,743 $37.51 p/Share	553 Added 8.29%	6,119 Common Stock
Feb 18 2021	BUY Exercise of conversion of derivative security	$1,131 $2.11 p/Share	536 Added 8.78%	5,566 Common Stock
Oct 06 2020	BUY Open market or private purchase	$95,570 $19.0 p/Share	5,030 Added 50.0%	5,030 Common Stock

Also insider at

FREQ

Frequency Therapeutics, Inc. Healthcare

Director

MAC

Marc A Cohen

Director

Watertown, MA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells CCCC shares.

Notify only if

Value

Insider Trading

Get notified when an C4 Therapeutics, Inc. insider buys or sells CCCC shares.

Notify only if

Operation

Value

Type

News

Receive news related to C4 Therapeutics, Inc.

Track Activities on CCCC

Account